Concepedia

Amy E. Schade

AE

7

Publications

350

Citations

7

H-Index

2019

Active since

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Boston University

Amy E. Schade is an author at Harvard University specializing in cell signaling, medicine, and cell division.

ORCID

Top concepts

Publications per year

2019–2024

7

Publications

7

Cyclin D–CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB

Amy E. Schade, Matthew G. Oser, Hilary E. Nicholson et al. · Oncogene · 2019 · 76 citations · Full text

, , +9

RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation

Amy E. Schade, Martin Fischer, James A. DeCaprio · Nucleic Acids Research · 2019 · 76 citations · Full text

STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells

Jong Wook Kim, Christian Berrios, Mi‐Ju Kim et al. · eLife · 2020 · 58 citations · Full text

AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

Amy E. Schade, Naiara Perurena, Yoona Yang et al. · Nature · 2024 · 49 citations · Full text

MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity

Timothy B. Branigan, David Kozono, Amy E. Schade et al. · Cell Reports · 2021 · 46 citations · Full text

, , +13

Rows per page

1–5 of 7